Report Detail
Global Biodefense Market Insights, Forecast to 2025
- RnM2849522 |
- 01 February, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The global Biodefense market is valued at 850 million US$ in 2018 and will reach 1500 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biodefense market based on company, product type, end user and key regions.
This report studies the global market size of Biodefense in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biodefense in these regions.
This research report categorizes the global Biodefense market by top players/brands, region, type and end user. This report also studies the global Biodefense market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Market size by Product
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Market size by End User
US Military Market
US Civilian Market
Non - US Market
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Biodefense market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Biodefense market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biodefense companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biodefense submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Biodefense are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biodefense market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Biodefense Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Biodefense Market Size Growth Rate by Product
- 1.4.2 Anthrax
- 1.4.3 Smallpox
- 1.4.4 Botulism
- 1.4.5 Radiation/Nuclear
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Biodefense Market Size Growth Rate by End User
- 1.5.2 US Military Market
- 1.5.3 US Civilian Market
- 1.5.4 Non - US Market
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biodefense Market Size
- 2.1.1 Global Biodefense Revenue 2014-2025
- 2.1.2 Global Biodefense Sales 2014-2025
- 2.2 Biodefense Growth Rate by Regions
- 2.2.1 Global Biodefense Sales by Regions
- 2.2.2 Global Biodefense Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Biodefense Sales by Manufacturers
- 3.1.1 Biodefense Sales by Manufacturers
- 3.1.2 Biodefense Sales Market Share by Manufacturers
- 3.1.3 Global Biodefense Market Concentration Ratio (CR5 and HHI)
- 3.2 Biodefense Revenue by Manufacturers
- 3.2.1 Biodefense Revenue by Manufacturers (2014-2019)
- 3.2.2 Biodefense Revenue Share by Manufacturers (2014-2019)
- 3.3 Biodefense Price by Manufacturers
- 3.4 Biodefense Manufacturing Base Distribution, Product Types
- 3.4.1 Biodefense Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biodefense Product Type
- 3.4.3 Date of International Manufacturers Enter into Biodefense Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Biodefense Sales by Product
- 4.2 Global Biodefense Revenue by Product
- 4.3 Biodefense Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Biodefense Breakdown Data by End User
6 North America
- 6.1 North America Biodefense by Countries
- 6.1.1 North America Biodefense Sales by Countries
- 6.1.2 North America Biodefense Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Biodefense by Product
- 6.3 North America Biodefense by End User
7 Europe
- 7.1 Europe Biodefense by Countries
- 7.1.1 Europe Biodefense Sales by Countries
- 7.1.2 Europe Biodefense Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Biodefense by Product
- 7.3 Europe Biodefense by End User
8 Asia Pacific
- 8.1 Asia Pacific Biodefense by Countries
- 8.1.1 Asia Pacific Biodefense Sales by Countries
- 8.1.2 Asia Pacific Biodefense Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Biodefense by Product
- 8.3 Asia Pacific Biodefense by End User
9 Central & South America
- 9.1 Central & South America Biodefense by Countries
- 9.1.1 Central & South America Biodefense Sales by Countries
- 9.1.2 Central & South America Biodefense Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Biodefense by Product
- 9.3 Central & South America Biodefense by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Biodefense by Countries
- 10.1.1 Middle East and Africa Biodefense Sales by Countries
- 10.1.2 Middle East and Africa Biodefense Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Biodefense by Product
- 10.3 Middle East and Africa Biodefense by End User
11 Company Profiles
- 11.1 Emergent Biosolutions
- 11.1.1 Emergent Biosolutions Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Emergent Biosolutions Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Emergent Biosolutions Biodefense Products Offered
- 11.1.5 Emergent Biosolutions Recent Development
- 11.2 Hytest
- 11.2.1 Hytest Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Hytest Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Hytest Biodefense Products Offered
- 11.2.5 Hytest Recent Development
- 11.3 GSK
- 11.3.1 GSK Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GSK Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GSK Biodefense Products Offered
- 11.3.5 GSK Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofi Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofi Biodefense Products Offered
- 11.4.5 Sanofi Recent Development
- 11.5 PharmAthene
- 11.5.1 PharmAthene Company Details
- 11.5.2 Company Business Overview
- 11.5.3 PharmAthene Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 PharmAthene Biodefense Products Offered
- 11.5.5 PharmAthene Recent Development
- 11.6 Bavarian Nordic
- 11.6.1 Bavarian Nordic Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Bavarian Nordic Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Bavarian Nordic Biodefense Products Offered
- 11.6.5 Bavarian Nordic Recent Development
- 11.7 SIGA Technologies
- 11.7.1 SIGA Technologies Company Details
- 11.7.2 Company Business Overview
- 11.7.3 SIGA Technologies Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 SIGA Technologies Biodefense Products Offered
- 11.7.5 SIGA Technologies Recent Development
- 11.8 Arbutus Biopharma
- 11.8.1 Arbutus Biopharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Arbutus Biopharma Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Arbutus Biopharma Biodefense Products Offered
- 11.8.5 Arbutus Biopharma Recent Development
- 11.9 DynPort Vaccine
- 11.9.1 DynPort Vaccine Company Details
- 11.9.2 Company Business Overview
- 11.9.3 DynPort Vaccine Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 DynPort Vaccine Biodefense Products Offered
- 11.9.5 DynPort Vaccine Recent Development
- 11.10 Xoma Corporation
- 11.10.1 Xoma Corporation Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Xoma Corporation Biodefense Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Xoma Corporation Biodefense Products Offered
- 11.10.5 Xoma Corporation Recent Development
- 11.11 Ichor Medical Systems
- 11.12 Aeolus Pharmaceuticals
- 11.13 Achaogen
- 11.14 Elusys Therapeutics
- 11.15 Dynavax Technologies
- 11.16 Cleveland BioLabs
- 11.17 Soligenix
- 11.18 Alnylam Pharmaceuticals
12 Future Forecast
- 12.1 Biodefense Market Forecast by Regions
- 12.1.1 Global Biodefense Sales Forecast by Regions 2019-2025
- 12.1.2 Global Biodefense Revenue Forecast by Regions 2019-2025
- 12.2 Biodefense Market Forecast by Product
- 12.2.1 Global Biodefense Sales Forecast by Product 2019-2025
- 12.2.2 Global Biodefense Revenue Forecast by Product 2019-2025
- 12.3 Biodefense Market Forecast by End User
- 12.4 North America Biodefense Forecast
- 12.5 Europe Biodefense Forecast
- 12.6 Asia Pacific Biodefense Forecast
- 12.7 Central & South America Biodefense Forecast
- 12.8 Middle East and Africa Biodefense Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biodefense Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biodefense . Industry analysis & Market Report on Biodefense is a syndicated market report, published as Global Biodefense Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Biodefense market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
